{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:49:49Z","timestamp":1760042989339,"version":"3.41.0"},"reference-count":28,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":1096,"URL":"https:\/\/www.cambridge.org\/core\/terms"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J. Law. Med. Ethics"],"published-print":{"date-parts":[[2018]]},"abstract":"<jats:p>The opioid epidemic has claimed the lives of more than 183,000 individuals since 1999 and is now the leading cause of accidental death in the United States. Meanwhile, rates of incarceration have quadrupled in recent decades, and drug use is the leading cause of incarceration. Medication-assisted treatment or MAT (i.e. methadone, buprenorphine) is the gold standard for treatment of opioid use disorder. Incarcerated individuals with opioid use disorder treated with methadone or buprenorphine have a lower risk of overdose, lower rates of hepatitis C transmission, and lower rates of re-incarceration. Despite evidence of improved outcomes, many jails and prisons do not offer MAT to individuals with opioid use disorder. This seems partly due to a scientifically unjustified preference for an abstinence-only treatment approach. The absence of MAT in prisons and jails results in poor outcomes for individuals and poses a public health threat to communities. Furthermore, it disproportionately harms poor communities and communities of color. Health care providers in prisons and jails have an ethical obligation to offer MAT to individuals with opioid use disorder to mitigate risk of infectious diseases, opioid overdose and health disparities associated with incarceration.<\/jats:p>","DOI":"10.1177\/1073110518782933","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T11:39:17Z","timestamp":1531913957000},"page":"268-271","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Our Ethical Obligation to Treat Opioid Use Disorder in Prisons: A Patient and Physician's Perspective"],"prefix":"10.1017","volume":"46","author":[{"given":"Curtis","family":"Bone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Eysenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Declan T.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,1,1]]},"reference":[{"key":"S107311050002533X_bib17","first-page":"453","article-title":"\u201cThe Case for Methadone Maintenance Treatment in Prisons,\u201d","volume":"27","author":"Boucher","year":"2003","journal-title":"Vermont Law Review"},{"key":"S107311050002533X_bib22","unstructured":"22. Id."},{"key":"S107311050002533X_bib14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.10.004"},{"key":"S107311050002533X_bib5","unstructured":"5. Fiellin, D. , Heimer, R. , Becker, W. , and D\u2019Onofrio, G. , DMHAS, \u201cThe Connecticut Opioid REsponse Initiative,\u201d October 5, 2016."},{"key":"S107311050002533X_bib28","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-014-0023-0"},{"key":"S107311050002533X_bib20","unstructured":"20. See Tsui, supra note 13."},{"key":"S107311050002533X_bib4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa064115"},{"key":"S107311050002533X_bib15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.06.015"},{"key":"S107311050002533X_bib8","unstructured":"8. Bureau of Justice Statistics, \u201cSubstance Dependence, Abuse, and Treatment of Jail Inmates, 2002\u201d, NCJ 209588, July 2005; and \u201cDrug Use and Dependence, State and Federal Prisoners, 2004,\u201d NCJ 213530, October 2006."},{"key":"S107311050002533X_bib2","unstructured":"2. NIDA, \u201cOverdose Death Rates: National Institute on Drug Abuse,\u201d January 6, 2017."},{"key":"S107311050002533X_bib6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-9-201311050-00005"},{"key":"S107311050002533X_bib10","unstructured":"10. \u201cCriminal Justice Fact Sheet,\u201d 2017, available at <http:\/\/www.naacp.org\/criminal-justice-fact-sheet> (last visited April 10, 2018)."},{"key":"S107311050002533X_bib1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm655051e1"},{"key":"S107311050002533X_bib19","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2011.611460"},{"key":"S107311050002533X_bib18","unstructured":"18. See Tsui, supra note 13."},{"key":"S107311050002533X_bib21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2014.08.015"},{"key":"S107311050002533X_bib3","unstructured":"3. Criminal Justice Facts: The Sentencing Project; 2017, available at <https:\/\/www.sentencingproject.org\/criminal-justice-facts\/> (last visited May 25, 2018)."},{"key":"S107311050002533X_bib27","unstructured":"27. Murphey, D. and Cooper, P.M. , \u201cParents Behind Bars: What Happens to Their Children?: Child Trends,\u201d October 2015, available at <https:\/\/www.childtrends.org\/wp-content\/uploads\/2015\/10\/2015-42ParentsBehindBars.pdf> (last visited May 25, 2018)."},{"key":"S107311050002533X_bib7","unstructured":"7. Id."},{"key":"S107311050002533X_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"\u00abChronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010,\u201d","volume":"160","author":"Denniston","year":"2014","journal-title":"Annal of Internal Medicine"},{"key":"S107311050002533X_bib16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01050.x"},{"key":"S107311050002533X_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.31887\/DCNS.2007.9.4\/hkleber","article-title":"\u201cPharmacologic Treatments for Opioid Dependence: Detoxification and Maintenance Options,\u201d","volume":"9","author":"Kleber","year":"2007","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"S107311050002533X_bib13","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.5416"},{"key":"S107311050002533X_bib23","unstructured":"23. NIDA, \u201cPrinciples of Drug Abuse Treatment for Criminal Justice Populations - A Research-Based Guide,\u201d National Institute on Drug Abuse (2014)."},{"key":"S107311050002533X_bib11","unstructured":"11. Id."},{"key":"S107311050002533X_bib25","unstructured":"25. Rabuy, B. and Kopf, D. , \u201cPrisons of Poverty: Uncovering the pre-incarceration incomes of the imprisoned,\u201d (2015), available at <https:\/\/www.prisonpolicy.org\/reports\/income.html> (last visited April 10, 2018)."},{"key":"S107311050002533X_bib9","first-page":"S135","article-title":"\u201cSocial Determinants and the Health of Drug Users: Socioeconomic Status, Homelessness, and Incarceration,\u201d","volume":"17","author":"Galea","year":"2002","journal-title":"Public Health Reports"},{"key":"S107311050002533X_bib26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfda.2013.09.038"}],"container-title":["Journal of Law, Medicine &amp; Ethics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1073110518782933","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1073110518782933","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S107311050002533X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T21:33:16Z","timestamp":1751751196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S107311050002533X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"alternative-id":["S107311050002533X"],"URL":"https:\/\/doi.org\/10.1177\/1073110518782933","relation":{},"ISSN":["1073-1105","1748-720X"],"issn-type":[{"type":"print","value":"1073-1105"},{"type":"electronic","value":"1748-720X"}],"subject":[],"published":{"date-parts":[[2018]]}}}